|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0013216,
umls-concept:C0017337,
umls-concept:C0023418,
umls-concept:C0023467,
umls-concept:C0026882,
umls-concept:C0027708,
umls-concept:C0032854,
umls-concept:C0041700,
umls-concept:C0043227,
umls-concept:C0332281,
umls-concept:C0333684,
umls-concept:C0683598,
umls-concept:C1514474,
umls-concept:C1518904,
umls-concept:C1551807,
umls-concept:C1556038,
umls-concept:C1561558,
umls-concept:C1563350,
umls-concept:C1563351
|
|
pubmed:issue |
33
|
|
pubmed:dateCreated |
2008-11-21
|
|
pubmed:abstractText |
To determine the clinical relevance of Wilms' tumor 1 (WT1) gene mutations in acute myeloid leukemia (AML) with normal karyotype (NK).
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AllenChristopherC,
pubmed-author:BonnetDominiqueD,
pubmed-author:BurnettAlanA,
pubmed-author:DrexlerHansH,
pubmed-author:FitzgibbonJudeJ,
pubmed-author:GaleRosemaryR,
pubmed-author:GreenClaireC,
pubmed-author:HillsRobertR,
pubmed-author:KakkasIoannisI,
pubmed-author:LinchDavidD,
pubmed-author:ListerT AndrewTA,
pubmed-author:QuentmeierHilmarH,
pubmed-author:StevensJaneJ,
pubmed-author:SummersKarinK,
pubmed-author:VirappanePriyaP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5429-35
|
|
pubmed:dateRevised |
2009-2-10
|
|
pubmed:meshHeading |
pubmed-meshheading:18591546-Adolescent,
pubmed-meshheading:18591546-Adult,
pubmed-meshheading:18591546-Disease-Free Survival,
pubmed-meshheading:18591546-Drug Resistance, Neoplasm,
pubmed-meshheading:18591546-Exons,
pubmed-meshheading:18591546-Female,
pubmed-meshheading:18591546-Genes, Wilms Tumor,
pubmed-meshheading:18591546-Humans,
pubmed-meshheading:18591546-Karyotyping,
pubmed-meshheading:18591546-Leukemia, Myeloid, Acute,
pubmed-meshheading:18591546-Male,
pubmed-meshheading:18591546-Middle Aged,
pubmed-meshheading:18591546-Mutation,
pubmed-meshheading:18591546-Prognosis,
pubmed-meshheading:18591546-Survival Rate,
pubmed-meshheading:18591546-Treatment Outcome,
pubmed-meshheading:18591546-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.
|
|
pubmed:affiliation |
Centre for Medical Oncology, Institute of Cancer, Barts and the London School of Medicine, Charterhouse Square, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
